Congrès mondial de dermatologie pédiatrique : principales séances et points importants à retenir
Résumé
Le Congrès mondial de dermatologie pédiatrique, qui s’est tenu à Buenos Aires, en Argentine, du 8 au 11 avril 2025, a été une occasion précieuse d’entendre des experts et d’obtenir des éclairages et des perspectives sur le domaine. Voici quelques points importants à retenir.
Références
Flohr C, Rosala-Hallas A, Jones AP, Beattie P, Baron S, Browne F, et al. Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial. Br J Dermatol. 2024 Jan 23;190(2):e13. doi: 10.1093/bjd/ljad442.] [published correction appears in Br J Dermatol. 2024 Jun 20;191(1):e1. doi: 10.1093/bjd/ljae157.] Br J Dermatol. 2023;189(6):674-684. doi:10.1093/bjd/ljad281
Kasap N, Kara A, Celik V, Bilgic Eltan S, Akay Haci I, Kose H, et al. Atypical localization of eczema discriminates DOCK8 or STAT3 deficiencies from atopic dermatitis. J Clin Immunol. 2023;43(8):1882-1890. doi:10.1007/s10875-023-01554-z
Huang JT, Coughlin CC, Hawryluk EB, Hook K, Humphrey SR, Kruse L, et al. Risk factors and outcomes of nonmelanoma skin cancer in children and young adults. J Pediatr. 2019;211:152-158. doi:10.1016/j.jpeds.2019.04.017
Takeichi T, Hsu CK, Yang HS, Chen HY, Wong TW, Tsai WL, et al. Progressive hyperpigmentation in a Taiwanese child due to an inborn error of vitamin B12 metabolism (cblJ). Br J Dermatol. 2015;172(4):1111-1115. doi:10.1111/bjd.13413
Gracci S, Novelli T, D’Elios S, Bernardini R, Peroni D. Hyper IgE syndromes. Curr Pediatr Rev. 2024;20(3):253-264. doi:10.2174/1573396320666230912103124
Atzmony L, Ugwu N, Hamilton C, Paller AS, Zech L, Antaya RJ, et al. Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders. Pediatr Dermatol. 2022;39(6):903-907. doi:10.1111/pde.15094
IJspeert H, Edwards ESJ, O’Hehir RE, Dalm V, van Zelm MC. Update on inborn errors of immunity. J Allergy Clin Immunol. 2025;155(3):740-751. doi:10.1016/j.jaci.2024.12.1075
Zhang Z, Lu Y, Shi C, Chen M, He X, Zhang H. Pediatric dermatofibrosarcoma protuberans: a clinicopathologic and genetic analysis of 66 cases in the largest institution in Southwest China. Front Oncol. 2023;13:1017154. doi:10.3389/fonc.2023.1017154
Fernandez ER, Tamura D, Khan SG, Momen S, Fassihi H, Sarkany R, et al. Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers. Front Oncol. 2023;13:1282823. doi:10.3389/fonc.2023.1282823
El Mansouri M, Essaddouki S, Mouradi M, Oukerroum A, El Fatoiki FZ, Truchuela MT, et al. Evaluation of the effectiveness and safety of combined oral and topical photoprotection with a standardized extract of Polypodium leucotomos (Fernblock(R)) in a Moroccan population with xeroderma pigmentosum. Photodermatol Photoimmunol Photomed. 2023;39(6):607-612. doi:10.1111/phpp.12904
Grootens-Wiegers P, Hein IM, van den Broek JM, de Vries MC. Medical decision-making in children and adolescents: developmental and neuroscientific aspects. BMC Pediatr. 2017;17(1):120. doi:10.1186/s12887-017-0869-x
Mazereeuw-Hautier J, Granier Tournier C, Hernandez-Martin A, Milesi S, Texier H, Severino-Freire M, et al. Biologics in congenital ichthyosis: are they effective? Br J Dermatol. 2025;192(2):327-334. doi:10.1093/bjd/ljae420
Nystrom A, Thriene K, Mittapalli V, Kern JS, Kiritsi D, Dengjel J, et al. Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms. EMBO Mol Med. 2015;7(9):1211-1228. doi:10.15252/emmm.201505061
Kiritsi D, Schauer F, Gewert S, Reineker K, Reimer-Taschenbrecker A, Schwieger-Briel A, et al. Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial. EClinicalMedicine. 2024;77:102900. doi:10.1016/j.eclinm.2024.102900
Olaiwan A, Chandesris MO, Fraitag S, Lortholary O, Hermine O, Fischer A, et al. Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis. J Am Acad Dermatol. 2011;65(6):1167-1172. doi:10.1016/j.jaad.2010.09.714
Agarwal S. Chronic granulomatous disease. J Clin Diagn Res. 2015;9(5):SD01-SD2. doi:10.7860/JCDR/2015/12139.5945
Stenerson M, Dufendach K, Aksentijevich I, Brady J, Austin J, Reed AM. The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist. Arthritis Rheum. 2011;63(12):4018-4022. doi:10.1002/art.30565
Ellingford JM, Black GC, Clayton TH, Judge M, Griffiths CE, Warren RB. A novel mutation in IL36RN underpins childhood pustular dermatosis. J Eur Acad Dermatol Venereol. 2016;30(2):302-305. doi:10.1111/jdv.13034
